Want to see LH full AI Analyst Report?

Labcorp Holdings (LH) Price & Analysis

Q: What was Labcorp Holdings’s price range in the past 12 months?

Labcorp Holdings lowest stock price was $244.52 and its highest was $341.80 in the past 12 months.

Q: What is Labcorp Holdings’s market cap?

Labcorp Holdings’s market cap is $26.51B.

Q: When is Labcorp Holdings’s upcoming earnings report date?

Labcorp Holdings’s upcoming earnings report date is Oct 22, 2026 which is in 44 days.

Q: How were Labcorp Holdings’s earnings last quarter?

Labcorp Holdings released its earnings results on Jul 30, 2026. The company reported $4.99 earnings per share for the quarter, beating the consensus estimate of $4.779 by $0.211.

Q: Is Labcorp Holdings overvalued?

According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does Labcorp Holdings pay dividends?

Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 0.88%. See more information on Labcorp Holdings dividends here

Q: What is Labcorp Holdings’s EPS estimate?

Labcorp Holdings’s EPS estimate is 4.65.

Q: How many shares outstanding does Labcorp Holdings have?

Labcorp Holdings has 81,100,000 shares outstanding.

Q: What happened to Labcorp Holdings’s price movement after its last earnings report?

Labcorp Holdings reported an EPS of $4.99 in its last earnings report, beating expectations of $4.779. Following the earnings report the stock price went up 2.728%.

Q: Which hedge fund is a major shareholder of Labcorp Holdings?

Currently, no hedge funds are holding shares in LH

1,175 Followers

LH Stock Chart & Stats

$336.54

$4.40(1.48%)

At close: Jul 27 4:00 PM EDT

$336.54

$4.40(1.48%)

Day’s Range― - ―

52-Week Range$244.52 - $341.80

Previous Close$301.91

Volume649.63K

Average Volume (3M)665.58K

Market Cap

$26.51B

Enterprise Value$29.60K

Total Cash (Recent Filing)$141.80M

Total Debt (Recent Filing)$6.77B

Price to Earnings (P/E)26.9

Beta0.33

Next Earnings

Oct 22, 2026

EPS Estimate

4.65

Next Dividend Ex-DateN/A

Dividend Yield0.88%

Share Statistics

EPS (TTM)12.17

Shares Outstanding81,100,000

10 Day Avg. Volume602,105

30 Day Avg. Volume665,577

Financial Highlights & Ratios

PEG Ratio1.28

Price to Book (P/B)2.42

Price to Sales (P/S)1.50

P/FCF Ratio17.31

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda<0.01

Forecast

1Y Price Target

$339.10

Price Target Upside0.76% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering12

EPS Forecast (FY)18.33

Revenue Forecast (FY)$14.74B

Bulls Say, Bears Say

Bulls Say

Revenue And Margin ExpansionBroad revenue growth and improved operating leverage indicate stronger execution across Labcorp’s platforms. Sustained volume, mix and productivity gains could support earnings growth over the next several quarters.

Biopharma Backlog VisibilityThe sizeable backlog and positive book-to-bill provide meaningful forward revenue visibility for Drug Development. This supports capacity planning, customer retention and more predictable growth despite uneven clinical-trial activity.

Expansion Of Specialty DiagnosticsAdding the first FDA-cleared single-biomarker blood test that can rule in and rule out amyloid pathology expands Labcorp’s specialty diagnostics offering. It may deepen provider relationships and support higher-value testing adoption.

Bears Say

Margins Below Historical PeakAlthough profitability is improving, margins remain well below prior peak levels, showing that the recovery is incomplete. Continued wage, reimbursement and operating-cost pressure could limit the durability of earnings growth.

Leverage And Cash FlexibilityMeaningful absolute debt combined with relatively low cash reduces financial flexibility if demand softens or investment needs rise. The recent free-cash-flow decline and imperfect earnings conversion further constrain debt reduction capacity.

PAMA Regulatory UncertaintyPotential changes to laboratory reimbursement under PAMA could pressure realized pricing and Diagnostics profitability. Uncertainty over implementation or delays makes long-term planning harder and may keep payer-policy risk elevated.

Labcorp Holdings News

Labcorp announces enhancements to Labcorp Global Trial Connect

Labcorp (LH) announced enhancements to the digital experience of Labcorp Global Trial Connect. The redesigned platform introduces new...

8d ago

Labcorp launches next generation of Labcorp Global Trial Connect

Labcorp (LH) announced enhancements to the digital experience of Labcorp Global Trial Connect. The newly redesigned platform introduces...

8d ago

Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease

Labcorp (LH) announced it will offer the Elecsys pTau-217 test following clearance by the U.S. FDA. Developed by...

15d ago

Labcorp, NACHC announce strategic alliance

Labcorp (LH) and the National Association of Community Health Centers announced a strategic alliance to strengthen leadership development,...

21d ago

Labcorp price target raised to $355 from $320 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Labcorp (LH) to $355 from $320 and keeps...

29d ago

Labcorp’s PGDx elio tissue complete CDx approved by FDA

Labcorp (LH) announced that the FDA has approved Labcorp’s PGDx elio tissue complete CDx as a companion diagnostic...

29d ago

Labcorp to Present at Morgan Stanley Healthcare Conference

Labcorp Holdings ( ($LH) ) has issued an announcement. Labcorp Holdings Inc., a global leader in diagnostics and...

11d ago

Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp

J.P. Morgan analyst Lisa Gill has maintained their bullish stance on LH stock, giving a Buy rating on...

13d ago

Labcorp Holdings Announces Investor Day to Outline Strategy

An update from Labcorp Holdings ( ($LH) ) is now available. Labcorp Holdings Inc., a major global laboratory...

22d ago

Labcorp Announces Leadership Realignment in Biopharma Labs

Labcorp Holdings ( ($LH) ) has shared an update. On August 11, 2026, Labcorp reported that Megan D....

25d ago

Labcorp launches FDA-approved PTEN companion diagnostic for prostate cancer

Labcorp (LH) announced the nationwide availability of Roche’s (RHHBY) VENTANA PTEN (SP218) RxDx Assay, the first immunohistochemistry companion...

1M ago

Labcorp price target raised to $309 from $300 at Piper Sandler

Piper Sandler analyst David Westenberg raised the firm’s price target on Labcorp (LH) to $309 from $300 following...

1M ago

Labcorp price target raised to $360 from $330 at JPMorgan

JPMorgan analyst Lisa Gill raised the firm’s price target on Labcorp (LH) to $360 from $330 and keeps...

1M ago

Labcorp price target raised to $338 from $308 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Labcorp (LH) to $338 from $308 and keeps an Overweight...

1M ago

LH FAQ

What was Labcorp Holdings’s price range in the past 12 months?

Labcorp Holdings lowest stock price was $244.52 and its highest was $341.80 in the past 12 months.

What is Labcorp Holdings’s market cap?

Labcorp Holdings’s market cap is $26.51B.

When is Labcorp Holdings’s upcoming earnings report date?

Labcorp Holdings’s upcoming earnings report date is Oct 22, 2026 which is in 44 days.

How were Labcorp Holdings’s earnings last quarter?

Labcorp Holdings released its earnings results on Jul 30, 2026. The company reported $4.99 earnings per share for the quarter, beating the consensus estimate of $4.779 by $0.211.

Is Labcorp Holdings overvalued?

According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Labcorp Holdings pay dividends?

Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 0.88%. See more information on Labcorp Holdings dividends here

What is Labcorp Holdings’s EPS estimate?

Labcorp Holdings’s EPS estimate is 4.65.

How many shares outstanding does Labcorp Holdings have?

Labcorp Holdings has 81,100,000 shares outstanding.

What happened to Labcorp Holdings’s price movement after its last earnings report?

Labcorp Holdings reported an EPS of $4.99 in its last earnings report, beating expectations of $4.779. Following the earnings report the stock price went up 2.728%.

Which hedge fund is a major shareholder of Labcorp Holdings?

Currently, no hedge funds are holding shares in LH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Labcorp Holdings Stock Smart Score

Outperform

Fundamentals

Return on Equity

0.88%

Trailing 12-Months

Asset Growth

2.62%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Labcorp Holdings

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Labcorp Holdings (LH) Earnings & Revenues

Historic Earnings Reports

LH Company Deck

LH Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call presented a strong operational and financial quarter: revenue growth, margin expansion, double-digit adjusted EPS growth, raised guidance, robust BLS backlog and book-to-bill, and multiple product/partnership launches. Headwinds highlighted were a meaningful quarter-over-quarter drop in free cash flow (timing and capex), a modest ACA-related volume headwind (~30 bps), prior and improving Early Development softness, higher patient-pay mix, and elevated absolute debt with relatively low cash on hand. On balance the positives around revenue, margins, guidance increases, product/market progress, and capital returns materially outweigh the cited challenges.View all LH earnings summaries

LH Revenue Breakdown

77.96% Dx

22.21% BLS

-0.16% Intercompany eliminations

LH Stock 12 Month Forecast

Average Price Target

$339.10

▲(0.76% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"248":"$248","305":"$305","362":"$362","276.5":"$276.5","333.5":"$333.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":361,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$361.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":339.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$339.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":306,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$306.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[248,276.5,305,333.5,362],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,327.61,330.17846153846153,332.7469230769231,335.31538461538463,337.88384615384615,340.4523076923077,343.02076923076925,345.58923076923077,348.1576923076923,350.72615384615386,353.2946153846154,355.8630769230769,358.4315384615385,{"y":361,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,327.61,328.49384615384616,329.3776923076923,330.26153846153846,331.1453846153846,332.02923076923076,332.9130769230769,333.7969230769231,334.6807692307693,335.5646153846154,336.4484615384616,337.3323076923077,338.2161538461539,{"y":339.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,327.61,325.9476923076923,324.2853846153846,322.62307692307695,320.96076923076924,319.29846153846154,317.63615384615383,315.9738461538462,314.3115384615385,312.64923076923077,310.98692307692306,309.3246153846154,307.6623076923077,{"y":306,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":275.206,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.265,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.416,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":265.758,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.032,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":268.299,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.073,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.41,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.593,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.32,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.272,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":308.538,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.61,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >